RecruitingPhase 1NCT03911388
Blood
Anaplastic ependymoma
5
studies recruiting now
as of 7 Sept 2026
120
studies registered in total
as of 7 Sept 2026
1
countries with a recruiting site
as of 7 Sept 2026
14 Mar 2022
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNot applicableNCT05057702
Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma
RecruitingPhase 1 / Phase 2NCT05278208
Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
RecruitingPhase 1NCT03750513
LET Optimized IMPT in Treating Pediatric Patients With Ependymoma
RecruitingPhase 1NCT04541082
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
Search all Anaplastic ependymoma studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Anaplastic ependymoma study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Anaplastic ependymoma
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
1 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Phase 2Marizomib
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).